The 2025 FPM Annual Symposium: Innovation in times of global uncertainty will explore how pharmaceutical medicine can play a vital role in addressing uncertainty and misinformation, helping bring clarity based on evidence, balance and equity.
We are continuously updating this section as we announce more speakers. Check back regularly for the latest additions to our expert speaker lineup.
Click on the following names to find out more about each speaker:
Chief Executive and Founding Director of the Science Media Centre
Fiona Fox is the Chief Executive and Founding Director of the Science Media Centre, which, since it was established in 2002, has become an indispensable resource for science journalists in the UK. She a has a degree in journalism and many years of experience working in media relations for high profile national organisations, including, amongst others, the Equal Opportunities Committee and the Catholic Agency for Overseas Devlopment (CAFOD).
She has received many accolades for her services to science, including an OBE, honorary fellowships of the Royal Society, the Academy of Medical Sciences, the Royal Society of Biology and the British Pharmacology Society. Fiona is also the author of ‘Beyond the Hype: Inside Science’s Biggest Media Scandals from Climategate to Covid’.
Non Executive Director at Compass Pathways
Dr Annalisa Jenkins MBBS FRCP is a life sciences thought leader with over 25 years of experience building and financing companies pursuing cures for the most challenging diseases globally. She has consistently mentored leadership teams advancing programs from basic research through clinical development, regulatory approval, and into healthcare systems globally.
Dr Jenkins graduated in Medicine at the University of London and received her Fellowship of the Royal College of Physicians London. She trained in Cardiovascular medicine and was a research fellow at Imperial College. Earlier in her career, Dr Jenkins was a medical officer in the British Royal Navy during the Gulf Conflict, achieving the rank of Surgeon Lieutenant Commander. She also held senior leadership roles at Merck Serono, and Bristol Myers-Squibb over 15 years. Dr Jenkins served as President and CEO of Dimension Therapeutics, a leading gene therapy company she took public on the NASDAQ and subsequently sold to Ultragenyx.
Following her relocation back to the UK, she developed a portfolio of roles spanning the public, private and charitable sectors including Genomics England, The King’s Fund, British Heart Foundation and Chair of YouBelong, a leading mental health care charity. She is also a Board member of several growing public and private companies including AVROBIO, COMPASS Pathways, Affimed and Mereo Biopharma. Dr Jenkins serves on a number of advisory boards and contributes publicly on leadership with purpose, social entrepreneurship, diversity and innovation.
Co-Chair of the BRIDGE Commission
Ngawai Moss works with families, researchers, clinicians and civil society organisations to ensure patient perspectives shape health research. She is a co-investigator on several studies and was recognised by Health Data Research (HDR) UK for her role in Patient and Public Involvement.
Ngawai co-chairs the Better Research, Information and Data Generation for Empowerment (BRIDGE) Commission, which focuses on improving reproductive health globally for women with chronic conditions. In 2024, she spoke at the Clinton Global Initiative during the UN General Assembly about the need for inclusive research that addresses existing data gaps. She also serves as an honorary research fellow at QMUL.
